survival
The density of tumor-infiltrating lymphocytes when combined with an analysis of tumor budding may serve as a method to more accurately predict survival in patients[...]
Despite improvements in median and short-term survival rates in glioblastoma, the percentage of patients achieving five-year survival remains low, according to new Mayo Clinic research.[...]
A new Mayo Clinic study suggests that some patients with pancreatic cancer could increase survival with adjustments to their chemotherapy regimen before surgery. Historically, most[...]